Materialise (MTLS) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Materialise NV reported a 6.2% increase in total revenue for Q2 2024, with significant growth in their Medical segment and stable gross profit margins. The company’s net result turned positive at 3,875 kEUR compared to a loss in Q2 2023, and they also experienced a solid cash flow from operating activities. The results indicate a strong financial position with an improved net cash standing and increased shareholder equity.
For further insights into MTLS stock, check out TipRanks’ Stock Analysis page.
